A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma

NCT04250064 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

DIPG

Interventions

DRUG: Bevacizumab Injection
RADIATION: Ultra-low-dose RT

Sponsor

Tata Memorial Centre